These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32333678)

  • 21. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
    Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
    J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A system for the mass combined vaccination of the adult population against influenza, viral hepatitis, typhoid, meningitis and diphtheria].
    Gapochko KG; Titova TS; Kharitonova VA; Misnikov OP; Savel'ev AP; Stepanov AV; Alliluev AP; Bichurina MA; Maksimova NM; Ozeretskovskiĭ NA
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (5):50-5. PubMed ID: 8067144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A two-dose combined vaccine against hepatitis A and hepatitis B in healthy children and adolescents compared to the corresponding monovalent vaccines.
    Ramonet M; da Silveira TR; Lisker-Melman M; Rüttimann R; Pernambuco E; Cervantes Y; Cañero-Velasco MC; Falleiros-Carvalho LE; Azevedo T; Targa-Ferreira C; Clemens SA
    Arch Med Res; 2002; 33(1):67-73. PubMed ID: 11825634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.
    Beran J
    Expert Rev Vaccines; 2007 Dec; 6(6):891-902. PubMed ID: 18377352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.
    Li F; Hu Y; Zhou Y; Chen L; Xia W; Song Y; Tan Z; Gao L; Yang Z; Zeng G; Han X; Li J; Li J
    Pediatr Infect Dis J; 2017 May; 36(5):e157-e161. PubMed ID: 28060048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Guillain-Barre syndrome after immunization with hepatitis A and typhoid vaccines].
    Uriondo San Juan B; Naval Valle D; Moreno Izcob F
    Aten Primaria; 2004 Oct; 34(7):379. PubMed ID: 15511361
    [No Abstract]   [Full Text] [Related]  

  • 27. Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course?
    Kallinowski B; Knöll A; Lindner E; Sänger R; Stremmel W; Vollmar J; Zieger B; Jilg W
    Vaccine; 2000 Aug; 19(1):16-22. PubMed ID: 10924782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines.
    Nothdurft HD; Dietrich M; Zuckerman JN; Knobloch J; Kern P; Sänger R
    BioDrugs; 2003; 17 Suppl 1():15-8. PubMed ID: 12785873
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.
    Khan MI; Soofi SB; Ochiai RL; Habib MA; Sahito SM; Nizami SQ; Acosta CJ; Clemens JD; Bhutta ZA;
    Vaccine; 2012 Aug; 30(36):5389-95. PubMed ID: 22721899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Sur D; Ochiai RL; Bhattacharya SK; Ganguly NK; Ali M; Manna B; Dutta S; Donner A; Kanungo S; Park JK; Puri MK; Kim DR; Dutta D; Bhaduri B; Acosta CJ; Clemens JD
    N Engl J Med; 2009 Jul; 361(4):335-44. PubMed ID: 19625715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children.
    Roberton D; Marshall H; Nolan TM; Sokal E; Díez-Domingo J; Flodmark CE; Rombo L; Lewald G; Flor Jde L; Casanovas JM; Verdaguer J; Marés J; Esso DV; Dieussaert I; Stoffel M
    Vaccine; 2005 Oct; 23(43):5099-105. PubMed ID: 16055231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficiency of combined immunization of children against typhoid and diphtheria; reactivity of the combined vaccine].
    ORLOVA GV
    Zh Mikrobiol Epidemiol Immunobiol; 1946; (1-2):58. PubMed ID: 20277187
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
    Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interchangeability of Hepatitis A boosters, Avaxim and Vaqta, in healthy adults following a primary dose of the combined typhoid/Hepatitis A vaccine Viatim.
    Ekwall E; Ulgemo A; Watson M; Boisnard F; Thomas S; Goullet F
    Vaccine; 2006 May; 24(20):4450-7. PubMed ID: 16621186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines.
    Jong EC; Kaplan KM; Eves KA; Taddeo CA; Lakkis HD; Kuter BJ
    J Travel Med; 2002; 9(2):66-70. PubMed ID: 12044272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
    Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
    Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
    J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of two doses of an inactivated hepatitis a vaccine given 6 months apart in healthy toddlers, children, and adolescents aged 12 months to 15 years in China: a phase IV study.
    Shi N; Rasuli A; Thollot Y
    Hum Vaccin Immunother; 2019; 15(3):748-754. PubMed ID: 30403910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis A vaccines.
    Shahidah KN
    Med J Malaysia; 2005 Jul; 60 Suppl B():112-5. PubMed ID: 16108190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.